ReviewJournal of hematology & oncology2019

Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy.

Shuang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.